MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts.
Payen L, Honorat M, Guitton J, Gauthier C, Bouard C, Lecerf-Schmidt F, Peres B, Terreux R, Gervot H, Rioufol C, Boumendjel A, Puisieux A, Di Pietro A.
Payen L, et al. Among authors: honorat m.
Oncotarget. 2014 Dec 15;5(23):11957-70. doi: 10.18632/oncotarget.2566.
Oncotarget. 2014.
PMID: 25474134
Free PMC article.